$SLAB

Silicon Labs faces earnings test amid Texas Instruments deal

Silicon Laboratories (SLAB) is set to report Q2 earnings Monday. Investors will assess whether its IoT chip bookings recovery persists while it awaits Texas Instruments’ planned $7.8 billion acquisition. Analysts expect EPS of 70 cents on revenue of $226.8 million. SLAB trades near $218.47, with a mean price target of $222.86.

Original reporting
Published Aug 9, 2026, 2:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 2:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SLAB
Neutral
medium confidence
Mentioned
$SLAB
Relevance
6/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$SLABNeutralMed
01

Why it matters

The market’s decision point is whether bookings recovery and design-win momentum translate into sustained revenue growth and profitability improvement, despite uncertainty around the pending merger.

02

Market read

This is an earnings-focused setup with explicit consensus figures and a clear checklist of what could drive upside or disappointment.

03

What to watch

The article emphasizes design wins and gross margin, but traders may also focus on forward guidance details, inventory/distributor channel health, and deal-related integration or regulatory timing risk.

Relevance 6/10Novelty 5/10Timing: ahead of Monday’s market-hours Q2 earnings release

Background

Silicon Labs (SLAB) is awaiting a $7.8B acquisition by Texas Instruments while preparing to report second-quarter earnings Monday during market hours.

Company-level read

Ticker impact

$SLABNeutralMedium confidence
Context

Silicon Labs is set to report Q2 earnings Monday, with investors focused on bookings recovery and the pending $7.8B Texas Instruments acquisition.

Expected impact

Near-term volatility likely around earnings, with upside skew if guidance supports sustained bookings and margin/operating leverage improvement.

Evidence & confidence

It provides consensus EPS/revenue expectations and highlights key watch items (bookings, design wins, gross margin, profitability trajectory) but does not disclose any new post-close results or fresh guidance beyond expectations.

Market effects

IoT and low-power wireless demand signals may influence sentiment across industrial IoT semiconductor names, especially if bookings normalization is confirmed.

Austin-based Silicon Labs earnings can affect local tech sentiment, but the article’s impact is primarily sector-wide rather than regional.

Texas Instruments’ pending acquisition overhang can affect broader analog/IoT supply-chain expectations and deal-risk pricing.

Counterpoint

Even if Q2 beats, investors may discount it if bookings acceleration is driven by temporary destocking normalization rather than durable end-demand.

Key entities

  • Silicon Laboratories Inc.

    IoT chipmaker scheduled to report Q2 earnings Monday; investors will assess bookings recovery, design wins, and margin/profitability trajectory.

  • Texas Instruments

    Pending acquirer of Silicon Labs in a $7.8B deal, creating deal-overhang uncertainty for near-term expectations.

Related articles

$SLABMed

Silicon Labs: Medical Revenue Surges 78% To Record As IoT Design Wins Accelerate

Silicon Labs reported Q2 total revenue of $228 million, up 18% year over year. Medical revenue rose 78% to a quarterly record, while Industrial & Commercial revenue increased 23% to $135 million and Home & Life rose 12% to $93 million. Non-GAAP diluted EPS was $0.71. The company cited accelerating IoT design wins and declining inventory; guidance is suspended due to its pending TI acquisition.

$SLABMedAI 8/10

Silicon Labs Reports Second Quarter 2026 Results

Silicon Labs (NASDAQ: SLAB) reported Q2 2026 revenue of $228 million, up 18% year over year. Industrial & Commercial revenue rose to $135 million, and Home & Life to $93 million. GAAP diluted EPS was -$0.32 and non-GAAP diluted EPS was $0.71. Gross margin was about 62%. The company suspended forward guidance due to its pending acquisition by Texas Instruments.

$SLABMed

SILICON LABORATORIES INC. (SLAB): Results of Operations and Financial Condition

SILICON LABORATORIES INC. (SLAB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99 Silicon Labs Reports Second Quarter 2026 Results Wireless IoT leader delivers $228 million in revenue and strong earnings growth AUSTIN, Texas – August 11, 2026 – Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, reported financial results for t

$TXNMedAI 9/10

Singapore’s competition watchdog clears Texas Instruments’ proposed acquisition of Silicon Labs

Singapore’s Competition and Consumer Commission (CCS) cleared Texas Instruments’ proposed acquisition of Silicon Labs, saying the deal will not substantially lessen competition in relevant global semiconductor markets. CCS reviewed market submissions and third-party feedback across five product categories and found pricing, quality, and choice would likely remain competitive post-transaction.

$TXNMed

Singapore’s competition watchdog seeks feedback on Texas Instruments’ proposed acquisition of Silicon Labs

Singapore’s Competition and Consumer Commission (CCS) opened a public consultation on Texas Instruments’ proposed acquisition of Silicon Laboratories, after accepting a joint application on Jul 3. CCS is assessing whether the deal could substantially lessen competition in Singapore. TI and Silicon Labs argue the transaction would not create competitive effects and that customers can switch suppliers. Feedback is due by Jul 22.

$TXNMed

Competition watchdog probes TI acquisition of Silicon labs

Singapore’s Competition and Consumer Commission (CCS) is reviewing Texas Instruments’ proposed acquisition of Silicon Laboratories to assess whether it could reduce competition in Singapore. CCS accepted a joint application on 3 July and opened a public consultation, with feedback due 22 July. The filing cites fragmented markets and limited product overlap, with customers able to switch suppliers.